NBAmine commited on
Commit
b26390b
·
verified ·
1 Parent(s): be1f806

Create README.md

Browse files
Files changed (1) hide show
  1. README.md +51 -0
README.md ADDED
@@ -0,0 +1,51 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ ---
2
+ language:
3
+ - en
4
+ base_model:
5
+ - Ultralytics/YOLOv5
6
+ - Ultralytics/YOLOv8
7
+ - Ultralytics/YOLO11
8
+ - microsoft/resnet-18
9
+ - google/vit-base-patch16-224
10
+ - microsoft/swin-tiny-patch4-window7-224
11
+ - facebook/convnext-tiny-224
12
+ pipeline_tag: image-classification
13
+ ---
14
+
15
+ # HAM10000 Skin Lesion Classification
16
+
17
+ <p align="center">
18
+ <a href="https://wandb.ai/nbamine-fsdm/ham10000-benchmarks">
19
+ <img src="https://img.shields.io/badge/Weights_&_Biases-FFBE00?style=for-the-badge&logo=WeightsAndBiases&logoColor=white" />
20
+ </a>
21
+ <a href="https://github.com/NBAmine/Vision-models-comparaison">
22
+ <img src="https://img.shields.io/badge/GitHub-181717?style=for-the-badge&logo=github&logoColor=white" />
23
+ </a>
24
+ </p>
25
+
26
+ ## Model Description
27
+ This model is a fine-tuned version of a computer vision architecture (YOLO, Transformer, or CNN) trained on the **HAM10000** dataset. The primary objective is the **binary classification** of skin lesions into two categories: **Benign** and **Malignant**. This work is part of a benchmark study evaluating modern architectures for dermatological triage.
28
+
29
+ - **Task:** Binary Image Classification
30
+ - **Dataset:** HAM10000 (Human Against Machine)
31
+ - **Classes:** Benign, Malignant
32
+ - **Developer:** NBAmine
33
+
34
+ ## Objective & Methodology
35
+ The goal of this project is to identify the most effective architecture for early skin cancer detection. We evaluate several models including:
36
+ - **YOLO Series:** v5n, v8n, 11n (Classification)
37
+ - **Transformers:** ViT-B/16, Swin Tiny
38
+ - **CNNs:** ResNet18, ConvNeXt Tiny
39
+
40
+ ### Training Highlights
41
+ - **Input Resolution:** 224x224 pixels.
42
+ - **Augmentation:** 180° rotations and flips to ensure rotation invariance.
43
+ - **Class Balancing:** Strategic oversampling of the Malignant class to mitigate dataset imbalance and improve clinical reliability.
44
+
45
+ ## Evaluation Metrics
46
+ The models are evaluated with a focus on sensitivity to ensure high detection rates for malignant cases:
47
+ - **Primary Metrics:** Recall (Malignant class), Macro F1-Score.
48
+ - **Secondary Metrics:** Accuracy, Precision, Validation Loss.
49
+
50
+ ## Intended Use
51
+ This model is intended for **research and educational purposes only**. It is designed as a decision-support tool for medical imaging analysis and is **not** a replacement for professional clinical diagnosis by a dermatologist.